Etiology of community acquired pneumonia in the Valencian Community (Spain). A multicentric prospective one-year survey Source: Eur Respir J 2004; 24: Suppl. 48, 242s Year: 2004
A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia Source: Eur Respir J 2001; 18: 362-368 Year: 2001
Impact of bacteremia in a cohort of predominantly elderly patients with pneumococcal pneumonia. Epidemiologic and case-control study Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002
Risk factors for community acquired pneumonia in German adults: a case-control study in the course of the competence network CAPNETZ Source: Eur Respir J 2006; 28: Suppl. 50, 456s Year: 2006
Epidemiological multicentre study on the incidence of RSV respiratory infections in early childhood in Italy Source: Eur Respir J 2002; 20: Suppl. 38, 17s Year: 2002
Epidemiological and clinical features of non tuberculous mycobacteria infection (NTM) in a five-year single centre experience Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016
A prospective comparison of nursing home acquired pneumonia (NAP) with community acquired pneumonia (CAP) Source: Eur Respir J 2005; 26: Suppl. 49, 257s Year: 2005
Medical history and clinical profile of childhood community acquired pneumonia (CAP) Source: Eur Respir J 2004; 24: Suppl. 48, 623s Year: 2004
Severe community acquired pneumonia: clinical and aetiological evaluation Source: Eur Respir J 2007; 30: Suppl. 51, 673s Year: 2007
Clinical failure in hospitalized patients with community acquired pneumonia (CAP): Preliminary results from the FAILCAP study Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011
Rapid syndromic PCR testing in a Norwegian cohort with suspected community acquired pneumonia Source: Virtual Congress 2021 – Pneumonia Year: 2021
Management of community acquired pneumonia audit Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Frequency of the occurrence of atypical pathogens in hospitalized patients with CAP: a multi-country study Source: Eur Respir J 2004; 24: Suppl. 48, 242s Year: 2004
Low frequency of resistant pathogens in nursing home acquired pneumonia: A prospective study and systematic review Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013
Prevalence, complications and evolution of community acquired pneumonia (CAP) in children in a secondary hospital in Brazil – 4 year‘s experience Source: Eur Respir J 2006; 28: Suppl. 50, 494s Year: 2006
Clinical profile and outcomes of patients with moderate and high risk community acquired pneumonia with mixed pathogens Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007
Risk factors (RF) for community-acquired pneumonia (CAP) in adults. A population-based case-control study Source: Eur Respir J 2002; 20: Suppl. 38, 419s Year: 2002
Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia Year: 2007
Preliminary results of the pilot pneumonia multicentric study in the GABRIEL network for etiological agents identification Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014